Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Pulmonary/Respiratory Diseases | Family Medicine
Disease Category: Non-Small Cell Lung Cancer
Location: United States, NJ
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
This research is being done because even with the most
aggressive after-surgery treatment with chemotherapy, many people
still have the lung cancer recur (come back).
The purpose of this study is to determine if adding the new drug
bevacizumab to chemotherapy improves the chance for cure for
patients who have had surgery for the removal of the lung cancer.
We will compare the effects (good and bad) of adding bevacizumab to
chemotherapy with standard chemotherapy alone on you and your lung
cancer to see which is better at preventing the cancer from coming
CW ID: 122109
Date Last Changed:
July 25, 2013
Cheryl Parish, RN, Manager, Oncology Clinical TrialsThe Valley Hospital/Valley Health SystemThe Daniel and Gloria Cancer Center
One Valley Health PlazaParamus, NJ 07652Phone: 201-634-5792
Research Center Information: The Valley Hospital/Valley Health System
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.